Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Anne Holm, Gloria Cordoba & Rune Aabenhus. (2019) Prescription of antibiotics for urinary tract infection in general practice in Denmark. Scandinavian Journal of Primary Health Care 37:1, pages 83-89.
Read now
Read now
Filip Jansåker, Niels Frimodt-Møller, Thomas L Benfield & Jenny Dahl Knudsen. (2018) Mecillinam for the treatment of acute pyelonephritis and bacteremia caused by Enterobacteriaceae: a literature review. Infection and Drug Resistance 11, pages 761-771.
Read now
Read now
Antonio Guglietta. (2017) Recurrent Urinary Tract Infections in Women: Risk Factors, Etiology, Pathogenesis and Prophylaxis. Future Microbiology 12:3, pages 239-246.
Read now
Read now
Petra Salomonsson, Marie-Louise von Linstow, Jenny Dahl Knudsen, Ida Heiberg, Gylli Mola, Therese Ramstad Wenger, Dina Cortes & Ulrikka Nygaard. (2016) Best oral empirical treatment for pyelonephritis in children: Do we need to differentiate between age and gender?. Infectious Diseases 48:10, pages 721-725.
Read now
Read now
Daniele Minardi, Gianluca d’Anzeo, Daniele Cantoro, Alessandro Conti & Giovanni Muzzonigro. (2011) Urinary tract infections in women: etiology and treatment options. International Journal of General Medicine 4, pages 333-343.
Read now
Read now
Articles from other publishers (20)
Jonas Tverring, Emeli Månsson, Vigith Andrews & Oskar Ljungquist. (2023) Pivmecillinam with Amoxicillin/Clavulanic acid as step down oral therapy in febrile Urinary Tract Infections caused by ESBL-producing Enterobacterales (PACUTI). Trials 24:1.
Crossref
Crossref
Antonietta Lucia Conte, Catia Longhi, Maria Pia Conte, Anna Maria Costanzo, Rosalba Paesano, Stefano Santangeli, Francesco Venditto, Giovanni Tripepi, Enrico Naldi, Giuditta Pollio, Valeria Cavallini, Marco Marrani, Patrizia Faltoni, Piera Valenti & Luigi Rosa. (2022) Effect of bovine lactoferrin on recurrent urinary tract infections: in vitro and in vivo evidences. BioMetals 36:3, pages 491-507.
Crossref
Crossref
Bjørn Åsheim Hansen, Nils Grude, Morten Lindbæk & Tore Stenstad. (2022) The efficacy of pivmecillinam in oral step-down treatment in hospitalised patients with E. coli bacteremic urinary tract infection; a single-arm, uncontrolled treatment study. BMC Infectious Diseases 22:1.
Crossref
Crossref
Sinead Duane, Claire Beecher, Akke Vellinga, Andrew W. Murphy, Martin Cormican, Andrew Smyth, Patricia Healy, Michael Moore, Paul Little & Declan Devane. (2022) A systematic review of the outcomes reported in the treatment of uncomplicated urinary tract infection clinical trials. JAC-Antimicrobial Resistance 4:2.
Crossref
Crossref
Ana Garcia-Sangenís, Rosa Morros, Mercedes Aguilar-Sánchez, Laura Medina-Perucha, Alfonso Leiva, Joana Ripoll, Mar Martínez-Pecharromán, Cruz B Bartolomé-Moreno, Rosa Magallon Botaya, Jaime Marín-Cañada, José M Molero, Ana Moragas, Amelia Troncoso, Ramon Monfà & Carl Llor. (2021) Clinical effectiveness and bacteriological eradication of three different Short-COurse antibiotic regimens and single-dose fosfomycin for uncomplicated lower Urinary Tract infections in adult women (SCOUT study): study protocol for a randomised clinical trial. BMJ Open 11:11, pages e055898.
Crossref
Crossref
Line Thousig Sehested, Konstantinos Kamperis, Louise Winding, Charlotte Kjær Bjerre, Mette Neland, Søren Hagstrøm, Line Kønig Wilms, Marie Louise Elkjær Andersen, Linda Kuhne‐Qvist, Jette Skjøde Hoffmann‐Petersen, Hanne Nørgaard & Dina Cortes. (2021) Children with acute pyelonephritis need medical re‐evaluation when home‐treated with oral antibiotics. Acta Paediatrica 110:9, pages 2627-2634.
Crossref
Crossref
Filiz ÖZTÜRK, Tuğba AYCAN & Ahmet Hilmi ÇON. (2020) Sülfametiyazol-2,2′-Bipiridin Tuzunun Yapısal ve Spektral İncelenmesi: Deneysel ve Moleküler Modelleme Çalışması. Bitlis Eren Üniversitesi Fen Bilimleri Dergisi 9:2, pages 525-541.
Crossref
Crossref
Filip Jansåker, Sara Thønnings, Frederik Boëtius Hertz, Thomas Kallemose, Jan Værnet, Lars Bjerrum, Thomas Benfield, Niels Frimodt-Møller & Jenny Dahl Knudsen. (2019) Three versus five days of pivmecillinam for community-acquired uncomplicated lower urinary tract infection: A randomised, double-blind, placebo-controlled superiority trial. EClinicalMedicine 12, pages 62-69.
Crossref
Crossref
Filip Jansåker, Marianne Bollestad, Ingvild Vik, Morten Lindbæk, Lars Bjerrum, Niels Frimodt-Møller & Jenny Knudsen. (2019) Pivmecillinam for Uncomplicated Lower Urinary Tract Infections Caused by Staphylococcus saprophyticus—Cumulative Observational Data from Four Recent Clinical Studies. Antibiotics 8:2, pages 57.
Crossref
Crossref
F. Caron, T. Galperine, C. Flateau, R. Azria, S. Bonacorsi, F. Bruyère, G. Cariou, E. Clouqueur, R. Cohen, T. Doco-Lecompte, E. Elefant, K. Faure, R. Gauzit, G. Gavazzi, L. Lemaitre, J. Raymond, E. Senneville, A. Sotto, D. Subtil, C. Trivalle, A. Merens & M. Etienne. (2018) Practice guidelines for the management of adult community-acquired urinary tract infections. Médecine et Maladies Infectieuses 48:5, pages 327-358.
Crossref
Crossref
Jennifer Kranz, Stefanie Schmidt, Cordula Lebert, Laila Schneidewind, Guido Schmiemann & Florian Wagenlehner. (2017) Uncomplicated Bacterial Community-Acquired Urinary Tract Infection in Adults. Deutsches Ärzteblatt international.
Crossref
Crossref
Mariona Pinart, Jennifer Kranz, Katrin Jensen, Tanja Proctor, Kurt Naber, Frank Kunath, Florian Wagenlehner & Stefanie Schmidt. (2017) Optimal dosage and duration of pivmecillinam treatment for uncomplicated lower urinary tract infections: a systematic review and meta-analysis. International Journal of Infectious Diseases 58, pages 96-109.
Crossref
Crossref
Hiba Zayyad, Noa Eliakim-Raz, Leonard Leibovici & Mical Paul. (2017) Revival of old antibiotics: needs, the state of evidence and expectations. International Journal of Antimicrobial Agents 49:5, pages 536-541.
Crossref
Crossref
Filip Jansåker, Niels Frimodt-Møller, Lars Bjerrum & Jenny Dahl Knudsen. (2016) The efficacy of pivmecillinam: 3 days or 5 days t.i.d against community acquired uncomplicated lower urinary tract infections – a randomized, double-blinded, placebo-controlled clinical trial study protocol. BMC Infectious Diseases 16:1.
Crossref
Crossref
B. Deyra, S. Ait Abdellah & A. Leblanc. (2016) Cystite et conseil officinal : intérêt d’un produit de phytothérapie associant des extraits de piloselle, de canneberge et d’orthosiphonCystitis and officinal council: relevance of a phytotherapeutic product combining extracts of hawkweed, cranberry and orthosiphon. Phytothérapie 14:5, pages 321-324.
Crossref
Crossref
Yu Ting Chen, Katzrin Ahmad Murad, Lily SY Ng, Jonathan TH Seah, Joon-Jae Park & Thean Yen Tan. (2016) In Vitro Efficacy of Six Alternative Antibiotics against Multidrug Resistant Escherichia Coli and Klebsiella Pneumoniae from Urinary Tract Infections. Annals of the Academy of Medicine, Singapore 45:6, pages 245-250.
Crossref
Crossref
Arne Søraas, Arnfinn Sundsfjord, Silje Bakken Jørgensen, Knut Liestøl & Pål A. Jenum. (2014) High Rate of Per Oral Mecillinam Treatment Failure in Community-Acquired Urinary Tract Infections Caused by ESBL-Producing Escherichia coli. PLoS ONE 9:1, pages e85889.
Crossref
Crossref
B. J. Knottnerus, L. Grigoryan, S. E. Geerlings, E. P. Moll van Charante, T. J. M. Verheij, A. G. H. Kessels & G. ter Riet. (2012) Comparative effectiveness of antibiotics for uncomplicated urinary tract infections: Network meta-analysis of randomized trials. Family Practice 29:6, pages 659-670.
Crossref
Crossref
F. Bruyère & J.-P. Boiteux. (2011) Épidémiologie, diagnostic et traitement des cystites aiguës isolées ou récidivantes de l'adulte. EMC - Urologie 4:3, pages 1-11.
Crossref
Crossref
F. Bruyère & J.-P. Boiteux. (2011) Epidemiología, diagnóstico y tratamiento de las cistitis agudas aisladas o recidivantes del adulto. EMC - Urología 43:4, pages 1-12.
Crossref
Crossref